Galliprant is a new NSAID on the market 3/2016 that is non-COX inhibiting, so it's in a different class than the traditional - NSAIDs. http://www.prnewswire.com/news-releases/...-300243759.htmlhttp://www.aratana.com/Galliprant
This is a human cell line p-glycoprotein substrate, which are the types of drugs that mdr1 dogs have difficulty with.
At this point, until tested by the canine mdr1 folks and given the okay, I would treat it as a canine mdr1 drug. Dogs considering it's use should be tested for the mdr1 mutation.